P06.10 Dose-response relationship of ALECSAT immunotherapy in autologous patient-derived glioblastoma stem cell cultures

Introduction: Glioblastoma (GBM) is a highly malignant brain tumor with dismal prognosis in which few treatment modalities have been proven efficacious. ALECSAT (Autologous Lymphoid Effector Cells Specific Against Tumour Cells) is a novel type of immunotherapy based on adoptively transferred autolog...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuro Oncol
Asıl Yazarlar: Werlenius, K., Wenger, A., Blomstrand, M., Jakola, A., Rydenhag, B., Carén, H.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2017
Konular:
POSTER PRESENTATIONS
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5463958/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox036.184
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller